Dr. Jinzi J. Wu is the Founder and CEO of Gannex which was founded in 2019, a wholly-owned company of Ascletis(1672.HK). Dr. Wu has more than 20-year experience covering R&D, GMP manufacturing and commercialization in Big Pharma and biotech. Prior to founding Ascletis and Gannex, he was the Vice President at GSK R&D in USA. He also held various R&D positions from Sr. Scientist to Vice President at Novartis, Immunex/Amgen and Ambrilia in USA and Canada. Dr. Wu obtained his Ph.D. in Cancer Biology from University of Arizona.